Zoya Angelova Spassova

Texture and color enhancement imaging versus white light imaging for the detection of colorectal adenomas: Systematic review and meta-analysis

Stefan Mitev, Humza Saeed, Ch Faizan Rasheed, Stefan Murvakov et autres

Abstract Texture and color enhancement imaging (TXI) is a novel optical technology designed to improve visibility during endoscopy by highlighting subtle differences in morphology and color. This systematic review and meta-analysis aimed to determine whether TXI, compared with conventional white light imaging …

bg, pk, us (code pays fourni par la source)

A Colorful Conundrum: Dark Urine in a Patient With Inflammatory Bowel Disease

Stefan Mitev, Cvetelina Marinova, Zoya Angelova Spassova

bg (code pays fourni par la source)

Intravenous versus subcutaneous delivery of biotherapeutics in IBD: an expert’s and patient’s perspective

Laimas Virginijus Jonaitis, Srdjan Z. Marković, Klaudia Farkas, Liana S. Gheorghe et autres

Several biologic treatments are available in addition to intravenous also in subcutaneous form for treatment of chronic diseases. Benefits of the subcutaneous application of drugs include self-administration by the patient, shorter time of application process with less infusion related adverse events and …

lt, rs, hu, ro, hr, ee, lv, bg, si (code pays fourni par la source)

Interleukin-6 compared to the other Th17/Treg related cytokines in inflammatory bowel disease and colorectal cancer

Tsvetelina Veselinova Velikova, Lyuba Dineva Miteva, Noyko Stanilov, Zoya Angelova Spassova et autres

BACKGROUNDThe connection between inflammatory bowel disease (IBD) and colorectal cancer (CRC) is well-established, as persistent intestinal inflammation plays a substantial role in both disorders.Cytokines may further influence the inflammation and the carcinogenesis process. AIMTo compare cytokine patterns of active IBD patients with …

gb, bg (code pays fourni par la source)

Retraction notice to “Alterations in cytokine gene expression profile in colon mucosa of inflammatory bowel disease patients on different therapeutic regimens” [Cytokine 92 (2017) 12–19]

Tsvetelina Veselinova Velikova, Dobroslav Stanimirov Kyurkchiev, Zoya Angelova Spassova, Iliya Karakolev et autres

bg (code pays fourni par la source)

Lamivudine today: Experience in a single Bulgarian center

Donika Krasteva, Deian Jelev, Krassimir Antonov, Zoya Angelova Spassova et autres

Lamivudine (LAM) is not recommended in the treatment of chronic hepatitis B due to high-rate of resistance: 49% to 70% after 3rd and 5th treatment year.LAM-resistance is more frequent in cases with high viral load or lack of complete HBV-DNA suppression within …

bg (code pays fourni par la source)

Lamivudine today: Experience in a single Bulgarian center

Donika Krasteva, Deian Jelev, Krassimir Antonov, Zoya Angelova Spassova et autres

Lamivudine (LAM) is not recommended in the treatment of chronic hepatitis B due to high-rate of resistance: 49% to 70% after 3rd and 5th treatment year.LAM-resistance is more frequent in cases with high viral load or lack of complete HBV-DNA suppression within …

bg (code pays fourni par la source)

Dynamics of Some Routine Immunological Parameters During Anti - TNF Therapy in Patients with Crohn’s Disease

Tsvetelina Veselinova Velikova, Zoya Angelova Spassova, Lyuben Mitkov Milatchkov, Dobriana Georgieva Panova et autres

Background: Fecal and immunological biomarkers can be used to diagnose and manage patients with Crohn's disease (CD).Antitumor necrosis factor (TNF) should be evaluated in addition to biomarkers to determine the response to therapy.Objectives: The current study aimed at following up fecal calprotectin …

bg (code pays fourni par la source)

Serological Update on Celiac Disease Diagnostics in Adults

Tsvetelina Veselinova Velikova, Zoya Angelova Spassova, Kalina D. Tumangelova-Yuzeir, Ekaterina Ivanova‐Todorova et autres

Celiac disease (CD) is an inflammatory disorder of the small intestines which serological diagnosis has come to the forefront with the development of the immunological testing. We aimed to explore the performance characteristics of a panel of serological tests in patients with …

bg (code pays fourni par la source)

Dynamics of Some Routine Immunological Parameters During Anti - TNF Therapy in Patients with Crohn’s Disease

Tsvetelina Veselinova Velikova, Zoya Angelova Spassova, Lyuben Mitkov Milatchkov, D. Panova et autres

Background: Fecal and immunological biomarkers can be used to diagnose and manage patients with Crohn’s disease (CD). Anti -tumor necrosis factor (TNF) should be evaluated in addition to biomarkers to determine the response to therapy.Objectives: The current study aimed at following up …

bg (code pays fourni par la source)

Primary Helicobacter pylori resistance in elderly patients over 20 years: A Bulgarian study

Lyudmila Boyanova, Galina Gergova, Rumyana Donkova Markovska, Nayden Kandilarov et autres

bg (code pays fourni par la source)

RETRACTED: Alterations in cytokine gene expression profile in colon mucosa of Inflammatory Bowel Disease patients on different therapeutic regimens

Tsvetelina Veselinova Velikova, Dobroslav Stanimirov Kyurkchiev, Zoya Angelova Spassova, Iliya Karakolev et autres

bg (code pays fourni par la source)